15.35 -0.16 (-1.03%)

45.33% Fall from 52W High

54,933 XNAS Volume

XNAS 24 Apr, 2025 12:21 PM (EDT)

Board Meeting
The next board meeting for Bicara Therapeutics Inc. is on 30 Apr 2025 for the purpose of Bicara Therapeutics Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for Bicara Therapeutics Inc.

The latest disclosure was made by Lara Meisner in Bicara Therapeutics Inc. where a trade of 79,146 Common Stock done at an average price of $5.5 was reported to US exchanges on March 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. 14 Mar 2025 79,146 79,145 - 5.5 431,346 Common Stock
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 12.69 per share. 14 Mar 2025 48,526 30,620 - 12.7 615,698 Common Stock
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 13.24 per share. 14 Mar 2025 30,620 0 - 13.2 405,513 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 48,720 107,187 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 30,246 67,119 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 1,080,775 1,080,775 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,327,365 4,443,122 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 3,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 9,990,144 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 40,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 432,736 432,736 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 324,552 324,552 - 0 Common Stock
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Scott Robertson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures